Global Selegiline Hydrochloride Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Selegiline Hydrochloride Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Selegiline Hydrochloride is the hydrochloride salt form of selegiline, a levorotatory acetylenic derivative of phenethylamine with antiparkinsonian effect. As a selective monoamine oxidase (MAO) inhibitor, selegiline has the greatest affinity for type B MAO, found mainly in the brain. Selegiline is converted by MAO B to an active moiety, which binds irreversibly at the active site of the enzyme's cofactor FAD (flavin adenine dinucleotide) molecule. This prevents the oxidative deamination of catecholamines and serotonin by MAO B, and leads to an increase in these neurotransmitters' activities resulting in improved motor function. In addition, this agent may inhibit re-uptake of dopamine by the neuron and prolong dopamine activity.
Selegiline Hydrochloride report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Selegiline Hydrochloride market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Parkinson's disease and Depression are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Selegiline Hydrochloride industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Selegiline Hydrochloride key manufacturers include Somerset Pharmaceuticals Inc., Mylan Specialty, Draxis Health Inc., Deprenyl Research Ltd., Golden State Medical Supply, Mayne Pharma, Endo Pharmaceuticals, Par Pharmaceutical and Apotex Corp., etc. Somerset Pharmaceuticals Inc., Mylan Specialty, Draxis Health Inc. are top 3 players and held % sales share in total in 2022.
Selegiline Hydrochloride can be divided into Tablet and Capsule, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Selegiline Hydrochloride is widely used in various fields, such as Parkinson's disease and Depression, etc. Parkinson's disease provides greatest supports to the Selegiline Hydrochloride industry development. In 2022, global % sales of Selegiline Hydrochloride went into Parkinson's disease filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Selegiline Hydrochloride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Somerset Pharmaceuticals Inc.
Mylan Specialty
Draxis Health Inc.
Deprenyl Research Ltd.
Golden State Medical Supply
Mayne Pharma
Endo Pharmaceuticals
Par Pharmaceutical
Apotex Corp.
A-S Medication Solutions
Segment by Type
Tablet
Capsule
Parkinson's disease
Depression
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Selegiline Hydrochloride market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Selegiline Hydrochloride, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Selegiline Hydrochloride industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Selegiline Hydrochloride in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Selegiline Hydrochloride introduction, etc. Selegiline Hydrochloride Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Selegiline Hydrochloride market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Selegiline Hydrochloride report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Selegiline Hydrochloride market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Parkinson's disease and Depression are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Selegiline Hydrochloride industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Selegiline Hydrochloride key manufacturers include Somerset Pharmaceuticals Inc., Mylan Specialty, Draxis Health Inc., Deprenyl Research Ltd., Golden State Medical Supply, Mayne Pharma, Endo Pharmaceuticals, Par Pharmaceutical and Apotex Corp., etc. Somerset Pharmaceuticals Inc., Mylan Specialty, Draxis Health Inc. are top 3 players and held % sales share in total in 2022.
Selegiline Hydrochloride can be divided into Tablet and Capsule, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Selegiline Hydrochloride is widely used in various fields, such as Parkinson's disease and Depression, etc. Parkinson's disease provides greatest supports to the Selegiline Hydrochloride industry development. In 2022, global % sales of Selegiline Hydrochloride went into Parkinson's disease filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Selegiline Hydrochloride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Somerset Pharmaceuticals Inc.
Mylan Specialty
Draxis Health Inc.
Deprenyl Research Ltd.
Golden State Medical Supply
Mayne Pharma
Endo Pharmaceuticals
Par Pharmaceutical
Apotex Corp.
A-S Medication Solutions
Segment by Type
Tablet
Capsule
Segment by Application
Parkinson's disease
Depression
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Selegiline Hydrochloride market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Selegiline Hydrochloride, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Selegiline Hydrochloride industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Selegiline Hydrochloride in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Selegiline Hydrochloride introduction, etc. Selegiline Hydrochloride Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Selegiline Hydrochloride market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices